American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized …

DR Anderson, GP Morgano, C Bennett… - Blood …, 2019 - ashpublications.org
Background: Venous thromboembolism (VTE) is a common source of perioperative
morbidity and mortality. Objective: These evidence-based guidelines from the American …

Risk of gastrointestinal bleeding in patients taking non–vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis

CS Miller, A Dorreen, M Martel, T Huynh… - Clinical Gastroenterology …, 2017 - Elsevier
Background & Aims Non–vitamin K antagonist oral anticoagulants (NOACs) are convenient
and effective in the prevention and treatment of venous thromboembolism and the …

Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous …

Y Shargall, W Wiercioch, A Brunelli… - European Journal of …, 2023 - academic.oup.com
Background Venous thromboembolism (VTE), which includes deep vein thrombosis and
pulmonary embolism, is a potentially fatal but preventable postoperative complication …

Efficacy and safety of commonly used thromboprophylaxis agents following hip and knee arthroplasty

T Cheok, A Beveridge, M Berman, M Coia… - Bone Joint …, 2024 - boneandjoint.org.uk
Efficacy and safety of commonly used thromboprophylaxis agents following hip and knee
arthroplasty Page 1 THE BONE & JOINT JOURNAL 924 T. Cheok, A. Beveridge, M. Berman, M …

Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis

S Lewis, J Glen, D Dawoud, S Dias, J Cobb… - The Lancet …, 2019 - thelancet.com
Background Hospital-associated venous thromboembolism is a major patient safety
concern. Provision of prophylaxis to patients admitted for elective total knee replacement …

New oral anticoagulants for venous thromboembolism prophylaxis in total hip and knee arthroplasty: a systematic review and network meta-analysis

Y Yi, S Gong, T Gong, L Zhou, C Hu… - Frontiers in Pharmacology, 2022 - frontiersin.org
Background: There is controversy over whether use of new oral anticoagulants (NOACs)
associates with increased hemorrhage risk compared with non-NOAC. Meanwhile …

Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta …

W Feng, X Wang, D Huang, A Lu - Pharmacological Research, 2021 - Elsevier
Background Anticoagulants are essential in the prevention of venous thromboembolism.
However, the effectiveness and safety of different anticoagulants have always been …

Pharmacotherapy for venous thromboprophylaxis following total hip or knee arthroplasty: a systematic review and network meta-analysis

BSJ Yong, RR Ling, R Li, JW Poh… - … in Thrombosis and …, 2024 - thieme-connect.com
The optimal pharmacological prophylaxis for venous thromboembolism (VTE) after hip or
knee arthroplasty is uncertain. We conducted a systematic review and network meta …

Major bleeding and case fatality rate with the direct oral anticoagulants in orthopedic surgery: a systematic review and meta-analysis

N Riva, F Dentali, ET Permunian… - Seminars in thrombosis …, 2016 - thieme-connect.com
The novel direct oral anticoagulants (DOACs) have been proposed as alternatives to low-
molecular-weight heparins (LMWHs) for the prevention of venous thromboembolism in …

[HTML][HTML] The safety and efficacy of NOACs versus LMWH for thromboprophylaxis after THA or TKA: A systemic review and meta-analysis

K Ding, W Yan, Y Zhang, J Li, C Li, C Liang - Asian Journal of Surgery, 2024 - Elsevier
The differences in the safety and efficacy of anticoagulation between different types of new
oral anticoagulants (NOACs) and low molecular weight heparin (LMWH) are still …